CALLUNA PHARMA AS
932255189ActiveClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Biotechnology Companycallunapharma.com
Yleiskatsaus
- 10
- Työntekijät
- 26.9milj NOK
- Liikevaihto
- 2023
- Perustettu
Avainpäättäjät
Susanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
+8 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Calluna Pharma is a global biotechnology company specializing in developing therapeutics focused on inflammation and fibrosis. Driven by a lean, committed team, the company is currently in the clinical stage of development. Their innovative approach targets upstream disease amplifiers using first-in...
ScandiBio Therapeutics AB